Latest Profit Growth News

Doctor Care Anywhere reported steady consultation growth and a third consecutive quarter of positive cashflow in Q4 2025, while advancing digital health pilots and reaffirming ambitious medium-term revenue and profitability goals.

EVZ Limited has reported its strongest quarterly cash position since inception, alongside profitable growth and an $80 million contract backlog, signalling robust momentum in its transition to a diversified industrial group.

FINEOS Corporation Holdings PLC reports a robust €27.8 million cash balance at the end of 2025, maintaining its FY25 revenue guidance despite seasonal cash flow dips and currency fluctuations.

Powerhouse Ventures reports its inaugural operating cash flow positive quarter alongside strong fund performance and strategic fund launches, signalling a turning point for the investment house.

EDU Holdings Limited anticipates FY25 financial results near the top of its guidance, driven by strong revenue and profit growth from its higher education arm, Ikon Institute.

Korvest Ltd reported a strong first half for FY2026 with revenue up 17.9% and profit before tax rising 33.2%, driven by growth in its Industrial Products segment and major infrastructure projects.

AMCIL Limited reported a 14.8% increase in half-year profit to $4.1 million, maintaining its interim dividend amid a portfolio return that lagged the ASX 200 benchmark.

Advanced Braking Technology Ltd reports a robust Q2 FY26 with a 34% increase in product sales revenue and a 191% jump in net profit before tax, underpinned by strong international expansion and domestic contract wins.

Mirrabooka Investments reported a 93.6% jump in half-year profit to $8.9 million, maintaining its fully franked dividend despite portfolio returns trailing the small and mid-cap benchmark.

Articore Group reports solid progress in its turnaround strategy, showing margin expansion and a slowing decline in marketplace revenue for 2QFY26 and 1HFY26.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.